BEAM logo

Beam Therapeutics (BEAM) Cash from operations

annual CFO:

-$347.25M-$198.05M(-132.75%)
December 31, 2024

Summary

  • As of today (June 28, 2025), BEAM annual cash flow from operations is -$347.25 million, with the most recent change of -$198.05 million (-132.75%) on December 31, 2024.
  • During the last 3 years, BEAM annual CFO has fallen by -$280.98 million (-424.00%).
  • BEAM annual CFO is now -1641.47% below its all-time high of $22.53 million, reached on December 31, 2022.

Performance

BEAM Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMcash flow metrics

quarterly CFO:

-$103.88M-$27.52M(-36.04%)
March 31, 2025

Summary

  • As of today (June 28, 2025), BEAM quarterly cash flow from operations is -$103.88 million, with the most recent change of -$27.52 million (-36.04%) on March 31, 2025.
  • Over the past year, BEAM quarterly CFO has dropped by -$4.14 million (-4.15%).
  • BEAM quarterly CFO is now -147.55% below its all-time high of $218.49 million, reached on March 31, 2022.

Performance

BEAM quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMcash flow metrics

TTM CFO:

-$351.38M-$4.14M(-1.19%)
March 31, 2025

Summary

  • As of today (June 28, 2025), BEAM TTM cash flow from operations is -$351.38 million, with the most recent change of -$4.14 million (-1.19%) on March 31, 2025.
  • Over the past year, BEAM TTM CFO has dropped by -$212.26 million (-152.56%).
  • BEAM TTM CFO is now -284.16% below its all-time high of $190.80 million, reached on March 31, 2022.

Performance

BEAM TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBEAMcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BEAM Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-132.8%-4.2%-152.6%
3 y3 years-424.0%-147.6%-284.2%
5 y5 years-382.3%-279.2%-377.8%

BEAM Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1641.5%at low-147.6%+5.4%-284.2%+0.6%
5 y5-year-1641.5%at low-147.6%+5.4%-284.2%+0.6%
alltimeall time-1641.5%at low-147.6%+5.4%-284.2%+0.6%

BEAM Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
-$103.88M(+36.0%)
-$351.38M(+1.2%)
Dec 2024
-$347.25M(+132.7%)
-$76.36M(-13.3%)
-$347.25M(+155.7%)
Sep 2024
-
-$88.13M(+6.2%)
-$135.81M(-1.2%)
Jun 2024
-
-$83.01M(-16.8%)
-$137.47M(-1.2%)
Mar 2024
-
-$99.75M(-173.8%)
-$139.13M(-6.7%)
Dec 2023
-$149.19M(-762.3%)
$135.07M(-250.4%)
-$149.19M(-57.8%)
Sep 2023
-
-$89.78M(+6.0%)
-$353.46M(+4.5%)
Jun 2023
-
-$84.67M(-22.9%)
-$338.17M(+10.6%)
Mar 2023
-
-$109.81M(+58.7%)
-$305.78M(-1457.4%)
Dec 2022
$22.53M(-134.0%)
-$69.19M(-7.1%)
$22.53M(-75.9%)
Sep 2022
-
-$74.50M(+42.5%)
$93.55M(-45.3%)
Jun 2022
-
-$52.28M(-123.9%)
$171.05M(-10.4%)
Mar 2022
-
$218.49M(>+9900.0%)
$190.80M(-387.9%)
DateAnnualQuarterlyTTM
Dec 2021
-$66.27M(-30.8%)
$1.83M(-39.1%)
-$66.27M(-28.3%)
Sep 2021
-
$3.01M(-109.2%)
-$92.40M(-20.8%)
Jun 2021
-
-$32.53M(-15.7%)
-$116.62M(+9.1%)
Mar 2021
-
-$38.58M(+58.8%)
-$106.93M(+11.7%)
Dec 2020
-$95.74M(+33.0%)
-$24.30M(+14.5%)
-$95.74M(+7.3%)
Sep 2020
-
-$21.21M(-7.1%)
-$89.24M(+5.0%)
Jun 2020
-
-$22.84M(-16.6%)
-$85.02M(+15.6%)
Mar 2020
-
-$27.39M(+53.9%)
-$73.54M(+2.1%)
Dec 2019
-$72.00M(+254.7%)
-$17.80M(+4.8%)
-$72.00M(+32.8%)
Sep 2019
-
-$16.99M(+49.7%)
-$54.20M(+45.7%)
Jun 2019
-
-$11.35M(-56.1%)
-$37.21M(+43.9%)
Mar 2019
-
-$25.86M
-$25.86M
Dec 2018
-$20.30M
-
-

FAQ

  • What is Beam Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Beam Therapeutics?
  • What is Beam Therapeutics annual CFO year-on-year change?
  • What is Beam Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Beam Therapeutics?
  • What is Beam Therapeutics quarterly CFO year-on-year change?
  • What is Beam Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Beam Therapeutics?
  • What is Beam Therapeutics TTM CFO year-on-year change?

What is Beam Therapeutics annual cash flow from operations?

The current annual CFO of BEAM is -$347.25M

What is the all time high annual CFO for Beam Therapeutics?

Beam Therapeutics all-time high annual cash flow from operations is $22.53M

What is Beam Therapeutics annual CFO year-on-year change?

Over the past year, BEAM annual cash flow from operations has changed by -$198.05M (-132.75%)

What is Beam Therapeutics quarterly cash flow from operations?

The current quarterly CFO of BEAM is -$103.88M

What is the all time high quarterly CFO for Beam Therapeutics?

Beam Therapeutics all-time high quarterly cash flow from operations is $218.49M

What is Beam Therapeutics quarterly CFO year-on-year change?

Over the past year, BEAM quarterly cash flow from operations has changed by -$4.14M (-4.15%)

What is Beam Therapeutics TTM cash flow from operations?

The current TTM CFO of BEAM is -$351.38M

What is the all time high TTM CFO for Beam Therapeutics?

Beam Therapeutics all-time high TTM cash flow from operations is $190.80M

What is Beam Therapeutics TTM CFO year-on-year change?

Over the past year, BEAM TTM cash flow from operations has changed by -$212.26M (-152.56%)
On this page